AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 188 filers reported holding AKERO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $139,112,597 | +15.1% | 2,750,348 | +6.3% | 0.01% | +20.0% |
Q2 2023 | $120,811,701 | +38.3% | 2,587,528 | +13.4% | 0.01% | +150.0% |
Q1 2023 | $87,331,128 | +7707.7% | 2,282,570 | +11083.0% | 0.00% | – |
Q4 2022 | $1,118,523 | -15.5% | 20,411 | -47.5% | 0.00% | – |
Q3 2022 | $1,324,000 | +26380.0% | 38,871 | +6578.9% | 0.00% | – |
Q2 2022 | $5,000 | – | 582 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ATP Life Science Ventures, L.P. | 5,830,203 | $179,512,000 | 24.20% |
venBio Partners LLC | 2,444,311 | $75,260,000 | 11.44% |
Versant Venture Management, LLC | 777,727 | $23,946,000 | 4.38% |
Redmile Group, LLC | 2,336,357 | $71,936,000 | 1.32% |
Vivo Capital, LLC | 571,833 | $17,607,000 | 1.02% |
Cormorant Asset Management, LP | 859,550 | $26,466,000 | 1.02% |
Boxer Capital, LLC | 831,495 | $25,602,000 | 0.88% |
Integral Health Asset Management, LLC | 85,000 | $2,617,000 | 0.80% |
EAM Global Investors LLC | 49,718 | $1,531,000 | 0.56% |
Crawford Lake Capital Management, LLC | 43,826 | $1,349,000 | 0.56% |